Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Gastric Cancer

Free Subscription Articles published in J Surg Oncol Retrieve available abstracts of 50 articles: HTML format

Single Articles

June 2025
1. BATES KR, Jones W, Liggett MR, Zaza NN, et al
   Complications Following Open Versus Minimally Invasive Resection of Gastric Adenocarcinoma.
   J Surg Oncol. 2025;131:1302-1312.
   PubMed     Abstract available
   
   
   
2. PRELA O, Caveney B, Strawderman M, Linehan D, et al
   A Reassessment of the Clinical Utility of (68)Ga-DOTATATE PET/CT in Patients With Gastroenteropancreatic Neuroendocrine Tumors.
   J Surg Oncol. 2025;131:1336-1342.
   PubMed     Abstract available
   
   
   
3. PETTIGREW MF, Kumar P, Nahi SL, Reznik SI, et al
   CT Scans Understage Lymph Nodes in Gastric and Gastroesophageal Adenocarcinoma.
   J Surg Oncol. 2025;131:1571-1579.
   PubMed     Abstract available
   
   
   May 2025
4. ZHOU X, Jiang Y, Xu H, Lin S, et al
   Modified Frailty Index Predicts Prognosis in Patients With Gastric Cancer After Gastrectomy: A Systematic Review and Meta-Analysis.
   J Surg Oncol. 2025 May 14. doi: 10.1002/jso.28136.
   PubMed     Abstract available
   
   
   March 2025
5. WANG YC, Liao YJ, Lin WT, Liao SC, et al
   Assessment of Endoscopic Ultrasound for Predicting Preoperative T Staging in Patients With Gastric Adenocarcinoma.
   J Surg Oncol. 2025;131:411-416.
   PubMed     Abstract available
   
   
   
6. LI MX, Lopez-Aguiar AG, Poultsides G, Rocha F, et al
   Preoperative Glycosylated Hemoglobin A1C Impacts Long-Term Outcomes Following Curative-Intent Resection of Nonfunctional Gastroenteropancreatic Neuroendocrine Tumors.
   J Surg Oncol. 2025;131:473-480.
   PubMed     Abstract available
   
   
   
7. KELLY NJ, Shafique N, Tortorello GN, Vargas G, et al
   Total Gastrectomy for Gastric Malignancy: Trends Over 15 Years in Major Morbidity, Mortality, and Patient Selection From The National Surgical Quality Improvement Program.
   J Surg Oncol. 2025;131:624-629.
   PubMed     Abstract available
   
   
   February 2025
8. SONG Y, Chen E, Chiang YJ, Yao JC, et al
   Classification of Gastric Neuroendocrine Tumors and Associations With Survival.
   J Surg Oncol. 2025;131:204-211.
   PubMed     Abstract available
   
   
   January 2025
9. DOBRZHANSKYI O, Gaskill CE, Kizub D, Kondratskyi Y, et al
   Utilization of Staging Laparoscopy for Patients With Gastric Cancer in Ukraine.
   J Surg Oncol. 2025 Jan 19. doi: 10.1002/jso.28095.
   PubMed     Abstract available
   
   
   December 2024
10. ZHU A, Kosyachkova E, Tiano T, Coburn NG, et al
    Letter to the Editor: Reporting of Core Outcomes in Gastric Cancer Surgical Trials Over the Past 25 Years (Systematic Review).
    J Surg Oncol. 2024 Dec 19. doi: 10.1002/jso.28057.
    PubMed    
    
    
    
11. GUL S, Alberto M, Annika K, Pratschke J, et al
    Emerging Treatment Modalities for Gastric Cancer With Macroscopic Peritoneal Metastases: A Systematic Review.
    J Surg Oncol. 2024 Dec 10. doi: 10.1002/jso.27987.
    PubMed     Abstract available
    
    
    
12. HU Q, Shi J, Yang X
    FLOT x8 for Gastric Cancer: Progress or Premature Optimism?
    J Surg Oncol. 2024 Dec 3. doi: 10.1002/jso.28028.
    PubMed    
    
    
    
13. VITELLO DJ, Zaza NN, Bates KR, Janczewski LM, et al
    Current National Treatment Trends for Gastric Adenocarcinoma in the United States.
    J Surg Oncol. 2024;130:1563-1572.
    PubMed     Abstract available
    
    
    
14. KHIABANY A, Dermanis AA, Liew MS, Ong KR, et al
    A Systematic Review of Surgical and Pathological Outcomes in Patients With a CDH1 Mutation Undergoing Total Gastrectomy.
    J Surg Oncol. 2024;130:1539-1550.
    PubMed     Abstract available
    
    
    November 2024
15. YIBREHU B, Mohammed TO, Murthy S, Aderibigbe AS, et al
    Gastric Cancer at a Nigerian Tertiary Referral Center: Experiences With Establishing an Institutional Cancer Registry.
    J Surg Oncol. 2024 Nov 18. doi: 10.1002/jso.27993.
    PubMed     Abstract available
    
    
    
16. JI ZH, Zhao QD, Li Y
    The Effects of HIPEC on Survival of Gastric Cancer Patients With Peritoneal Metastasis.
    J Surg Oncol. 2024 Nov 17. doi: 10.1002/jso.27877.
    PubMed     Abstract available
    
    
    October 2024
17. KLINGBEIL KD, Eng IK, Dube P, Dillon DL, et al
    CT Imaging as a Single Modality for Clinical Staging of Gastric Cancer in Limited Resource Centers: A Retrospective Pilot Study.
    J Surg Oncol. 2024 Oct 15. doi: 10.1002/jso.27857.
    PubMed     Abstract available
    
    
    
18. RENCUZOGULLARI A, Karahan SN, Selcukbiricik F, Lacin S, et al
    The New Era of Total Neoadjuvant FLOT Therapy for Locally Advanced, Resectable Gastric Cancer: A Propensity-Matched Comparison With Standard Perioperative Therapy.
    J Surg Oncol. 2024 Oct 13. doi: 10.1002/jso.27934.
    PubMed     Abstract available
    
    
    
19. AJAY PS, Mavani PT, Sok CP, Goyal S, et al
    Comparison of treatment strategies based on clinical and pathological nodal status in resectable gastric adenocarcinoma.
    J Surg Oncol. 2024;130:1078-1091.
    PubMed     Abstract available
    
    
    September 2024
20. ARARUNA GF, Ribeiro HSC, Torres SM, Diniz AL, et al
    Impact of Minimally Invasive Surgery on Early and Late Outcomes of Patients With Gastric Cancer Treated Using Neoadjuvant Chemotherapy.
    J Surg Oncol. 2024 Sep 19. doi: 10.1002/jso.27904.
    PubMed     Abstract available
    
    
    
21. RAMOS MFKP, Gusmao JS, Pereira MA, Ribeiro-Junior U, et al
    Textbook outcome for evaluating the surgical quality of gastrectomy.
    J Surg Oncol. 2024;130:769-775.
    PubMed     Abstract available
    
    
    
22. RAMOS MFKP, Pereira MA, Santos SM, Dias AR, et al
    Gastrectomies for the treatment of gastric cancer in a reference cancer center present better pathological results and survival compared to non-specialized hospitals.
    J Surg Oncol. 2024;130:750-756.
    PubMed     Abstract available
    
    
    
23. PEREIRA MA, Ramos MFKP, Dias AR, Yagi OK, et al
    Adjuvant chemotherapy versus preoperative chemotherapy for gastric cancer treated with curative-intent resection: A propensity score-matched analysis.
    J Surg Oncol. 2024;130:724-733.
    PubMed     Abstract available
    
    
    
24. DA SILVA GOMES S, Oliveira CS, Furtado TA, Melo LM, et al
    Recurrence of fusocellular subtype GIST with SDHB mutation: A case of SDHB-loss and therapeutic challenges.
    J Surg Oncol. 2024;130:741-742.
    PubMed     Abstract available
    
    
    
25. LIMA CAC, Martins MR, Dos Santos RL, da Silva LM, et al
    Soluble levels of 4-1BB (CD137) and OX40 (CD134) are associated with cancer progression in gastric adenocarcinoma.
    J Surg Oncol. 2024;130:734-740.
    PubMed     Abstract available
    
    
    August 2024
26. KITAI T, Yamanaka K
    Conversion surgery for gastric cancer with PM.
    J Surg Oncol. 2024 Aug 19. doi: 10.1002/jso.27794.
    PubMed     Abstract available
    
    
    July 2024
27. TAKAHASHI H, Nakauchi M, Hiotis S, Datta R, et al
    Neoadjuvant chemotherapy for resectable gastric cancer is associated with better outcomes than neoadjuvant chemoradiation.
    J Surg Oncol. 2024 Jul 31. doi: 10.1002/jso.27761.
    PubMed     Abstract available
    
    
    
28. CASS SH, Williams LA, Rajaram R, Hirata Y, et al
    Patient-reported outcome measures in surgical patients with upper gastrointestinal cancers: A qualitative interview study.
    J Surg Oncol. 2024;130:117-124.
    PubMed     Abstract available
    
    
    June 2024
29. DA SILVA LM, Martins MR, Dos Santos RL, Da Silva JPA, et al
    Evaluation of soluble co-inhibitors and co-stimulators levels of the immune response in gastric cancer.
    J Surg Oncol. 2024 Jun 30. doi: 10.1002/jso.27747.
    PubMed     Abstract available
    
    
    
30. SOUZA WP, Pereira MA, Cardili L, Zilberstein B, et al
    Evaluation of the endoscopic cure criteria in patients undergoing surgery for early gastric cancer.
    J Surg Oncol. 2024 Jun 27. doi: 10.1002/jso.27745.
    PubMed     Abstract available
    
    
    
31. JANCZEWSKI LM, Buchheit J, Jacobs RC, Vitello D, et al
    Utilization and survival outcomes of neoadjuvant chemotherapy for early-stage gastric cancer.
    J Surg Oncol. 2024 Jun 17. doi: 10.1002/jso.27732.
    PubMed     Abstract available
    
    
    May 2024
32. JANCZEWSKI LM, Bentrem DJ, Chawla A
    Response to comment on: "Comparison of perioperative and histopathologic outcomes among neoadjuvant treatment strategies for locoregional gastric cancer".
    J Surg Oncol. 2024 May 27. doi: 10.1002/jso.27678.
    PubMed    
    
    
    
33. DA COSTA WL JR,, Tan MC, Camp ER, Thrift AP, et al
    Patient- and system-level factors associated with racial/ethnic disparities in the delivery of guideline-concordant therapy among US patients with gastric cancer.
    J Surg Oncol. 2024 May 16. doi: 10.1002/jso.27683.
    PubMed     Abstract available
    
    
    
34. CORSO G, Davis JL, Strong VE
    Points to consider regarding prophylactic total gastrectomy in germline CDH1 variant carriers.
    J Surg Oncol. 2024;129:1082-1088.
    PubMed     Abstract available
    
    
    April 2024
35. LI C, Qu M, Ye Y, Zhu F, et al
    Letter to the Editor: Comment on: "Comparison of perioperative and histopathologic outcomes among neoadjuvant treatment strategies for locoregional gastric cancer".
    J Surg Oncol. 2024 Apr 29. doi: 10.1002/jso.27667.
    PubMed    
    
    
    
36. DIAS AR, Pereira MA, Ramos MFKP, de Oliveira RJ, et al
    Robotic versus laparoscopic gastrectomy for gastric cancer: A Western propensity score matched analysis.
    J Surg Oncol. 2024 Apr 17. doi: 10.1002/jso.27651.
    PubMed     Abstract available
    
    
    March 2024
37. NAQVI A, Matias N, Al-Khaffaf B
    Reporting of core outcomes in gastric cancer surgery trials over the past 25 years (systematic review).
    J Surg Oncol. 2024 Mar 6. doi: 10.1002/jso.27613.
    PubMed     Abstract available
    
    
    
38. KIM JY, Love M, Woo Y, Campos B, et al
    Pilot study of a telehealth intervention for personalized self-management for eating symptoms after gastroesophageal cancer surgery.
    J Surg Oncol. 2024;129:728-733.
    PubMed     Abstract available
    
    
    February 2024
39. LILLEY EJ, Lu P, Robinson K, Griffith H, et al
    High symptom burden in patients undergoing gastrectomy for cancer.
    J Surg Oncol. 2024;129:228-232.
    PubMed     Abstract available
    
    
    January 2024
40. HONDO N, Yamamoto Y, Nakabe T, Otsubo T, et al
    Short-term outcomes of laparoscopic and robotic distal gastrectomy for gastric cancer: Real-world evidence from a large-scale inpatient database in Japan.
    J Surg Oncol. 2024 Jan 4. doi: 10.1002/jso.27575.
    PubMed     Abstract available
    
    
    
41. VAN DER WIELEN N, Brenkman H, Seesing M, Daams F, et al
    Minimally invasive versus open gastrectomy for gastric cancer. A pooled analysis of two European randomized controlled trials.
    J Surg Oncol. 2024 Jan 4. doi: 10.1002/jso.27578.
    PubMed     Abstract available
    
    
    
42. SESTITO M, Pratt H, Schmidt C, Thomay A, et al
    Recent advances for treatment of upper gastrointestinal malignancy.
    J Surg Oncol. 2024;129:48-62.
    PubMed     Abstract available
    
    
    December 2023
43. CASPERS IA, Slagter AE, Lind P, Sikorska K, et al
    The impact of sex on treatment and outcome in relation to histological subtype in patients with resectable gastric cancer: Results from the randomized CRITICS trial.
    J Surg Oncol. 2023 Dec 10. doi: 10.1002/jso.27554.
    PubMed     Abstract available
    
    
    
44. KARALIS JD, Ju MR, Feig R, Estrella R, et al
    Intensifying supportive care is associated with improved survival in gastric cancer patients with malignant ascites.
    J Surg Oncol. 2023 Dec 8. doi: 10.1002/jso.27556.
    PubMed     Abstract available
    
    
    November 2023
45. JANCZEWSKI LM, Logan CD, Vitello DJ, Buchheit JT, et al
    Comparison of perioperative and histopathologic outcomes among neoadjuvant treatment strategies for locoregional gastric cancer.
    J Surg Oncol. 2023 Nov 20. doi: 10.1002/jso.27521.
    PubMed     Abstract available
    
    
    October 2023
46. MAVANI PT, Ajay PS, Goyal S, Shah MM, et al
    Reply to: Striking a balance: Deciphering the dilemma of treatment equivalence in cardia gastric cancer.
    J Surg Oncol. 2023 Oct 17. doi: 10.1002/jso.27483.
    PubMed    
    
    
    
47. LOUAFI MO, Lahnaoui O, Benkabbou A, Majbar MA, et al
    Striking a balance: Deciphering the dilemma of treatment equivalence in cardia gastric cancer.
    J Surg Oncol. 2023 Oct 16. doi: 10.1002/jso.27452.
    PubMed    
    
    
    June 2023
48. JANCZEWSKI LM, Shah D, Wells A, Bentrem DJ, et al
    The inaccuracies of gastric adenocarcinoma clinical staging and its predictive factors.
    J Surg Oncol. 2023;127:1116-1124.
    PubMed     Abstract available
    
    
    April 2023
49. AJAY PS, Sok CP, Goyal S, Switchenko JM, et al
    Impact of nodal status in determining multimodal treatment strategies in non-cardia gastric cancer.
    J Surg Oncol. 2023 Apr 28. doi: 10.1002/jso.27297.
    PubMed     Abstract available
    
    
    
50. AJAY PS, NeMoyer R, Goyal S, Switchenko JM, et al
    Does non-metastatic gastric cancer of the cardia warrant a different treatment strategy?
    J Surg Oncol. 2023 Apr 10. doi: 10.1002/jso.27276.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Gastric Cancer is free of charge.